Skip to main content
    N

    NRC Health (NRC)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $26.33
    -0.23 (-0.87%)

    Market Cap: $563.64M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    NRC Health (NRC) Earnings: Report Dates and Results

    Updated Oct 27, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    NRC Health (NRC) is expected to report earnings on Feb 1, 2027. In the quarter ended Sep 30, 2026, NRC Health reported EPS of $0.21, in line with the $0.21 estimate. It beat the EPS estimate in 4 of the 8 most recent quarters that had an estimate.

    Earnings

    Performance (10Y)

    Beat Rate
    56%(10/18)
    Avg Surprise
    +1.81%

    Upcoming Estimates

    Reports Apr 26, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus$0.23
    Range$0.23 - $0.23
    1 analysts
    EPS Revisions
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$0.24-4.2%
    60d ago$0.24-4.2%
    30d ago$0.24-4.2%
    7d ago$0.24-4.2%
    Current$0.23
    Revenue Consensus
    $37.20M
    Range$37.20M - $37.20M
    1 analysts

    Next Report

    NRC has an expected report date of Feb 1, 2027. Analysts' consensus for the quarter ending Mar 31, 2027 is 64.3% above the $0.14 reported for the quarter ended Mar 31, 2026.

    NRC Earnings Call

    The latest NRC earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 18 quarters below that had an estimate, NRC beat 10, missed 4 and matched 4. Revenue for the quarter ended Sep 30, 2026 was $38.40M, up 11.0% from $34.61M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$0.21$0.21$0.21 - $0.210.00%In line+16.3%10 up, 0 downOct 27, 2026$38.40M
    Jun 30, 2026$0.31$0.14$0.14 - $0.14+121.43%BeatN/A10 up, 0 downJul 28, 2026$35.39M
    Mar 31, 2026$0.14N/AN/AN/AN/A-44.0%N/AN/AApr 28, 2026$34.80M
    Dec 31, 2025$0.08N/AN/AN/AN/A-70.7%N/AN/AFeb 3, 2026$35.19M
    Sep 30, 2025$0.18N/AN/AN/AN/A-24.6%N/AN/AOct 27, 2025$34.61M
    Jun 30, 2025-$0.01N/AN/AN/AN/A-103.9%N/AN/AJul 28, 2025$34.04M
    Mar 31, 2025$0.25N/AN/AN/AN/A-5.1%N/AN/AApr 28, 2025$33.55M
    Dec 31, 2024$0.28N/AN/AN/AN/A-22.0%N/AN/AFeb 11, 2025$36.91M
    Sep 30, 2024$0.24N/AN/AN/AN/A-25.2%N/AN/AOct 25, 2024$35.82M
    Jun 30, 2024$0.26N/AN/AN/AN/A-11.0%N/AN/AAug 6, 2024$35.02M
    Mar 31, 2024$0.27N/AN/AN/AN/A-5.3%N/AN/AMay 7, 2024$35.31M
    Dec 31, 2023$0.36$0.36N/A0.00%In line+33.3%N/AN/AFeb 13, 2024$38.00M
    Sep 30, 2023$0.32$0.32N/A0.00%In line-3.0%N/AN/ANov 7, 2023$37.95M
    Jun 30, 2023$0.29$0.29N/A0.00%In line-12.1%N/AN/AAug 1, 2023$36.16M
    Mar 31, 2023$0.28N/AN/AN/AN/A-17.6%N/AN/AMay 2, 2023$36.47M
    Dec 31, 2022$0.27N/AN/AN/AN/A-28.9%N/AN/AFeb 14, 2023$38.14M
    Sep 30, 2022$0.33N/AN/AN/AN/A-13.2%N/AN/ANov 1, 2022$37.69M
    Jun 30, 2022$0.33N/AN/AN/AN/A-5.7%N/AN/AAug 2, 2022$37.29M
    Mar 31, 2022$0.34N/AN/AN/AN/A-5.6%N/AN/AMay 3, 2022$38.44M
    Dec 31, 2021$0.38N/AN/AN/AN/A+18.8%N/AN/AFeb 8, 2022$38.30M
    Sep 30, 2021$0.38N/AN/AN/AN/A+2.7%N/AN/ANov 2, 2021$37.77M
    Jun 30, 2021$0.35N/AN/AN/AN/A+16.7%N/AN/AAug 3, 2021$36.42M
    Mar 31, 2021$0.36N/AN/AN/AN/A-21.7%N/AN/AMay 4, 2021$35.46M
    Dec 31, 2020$0.32N/AN/AN/AN/A-5.9%N/AN/AFeb 9, 2021$34.77M
    Sep 30, 2020$0.37N/AN/AN/AN/A+19.4%N/AN/ANov 3, 2020$33.48M
    Jun 30, 2020$0.30N/AN/AN/AN/A+3.4%N/AN/AAug 4, 2020$31.17M
    Mar 31, 2020$0.46N/AN/AN/AN/A+43.8%N/AN/AMay 5, 2020$33.86M
    Dec 31, 2019$0.34$0.30N/A+13.33%Beat+13.3%N/A0 up, 0 downFeb 11, 2020$32.62M
    Sep 30, 2019$0.31$0.29N/A+6.90%Beat+14.8%N/A0 up, 0 downNov 5, 2019$32.47M
    Jun 30, 2019$0.29$0.26$0.26 - $0.26+11.54%Beat+3.6%1N/AAug 6, 2019$31.41M
    Mar 31, 2019$0.32$0.31N/A+3.23%Beat+10.3%N/AN/AMay 7, 2019$31.48M
    Dec 31, 2018$0.30$1.05N/A-71.43%Miss+100.0%N/AN/AFeb 12, 2019$30.64M
    Sep 30, 2018$0.27$0.98N/A-72.45%Miss+68.8%N/AN/ANov 6, 2018$30.01M
    Jun 30, 2018$0.28$0.22N/A+27.27%Beat+21.7%1N/AAug 7, 2018$28.02M
    Mar 31, 2018$0.29$0.25N/A+16.00%Beat+11.5%1N/AMay 1, 2018$31.02M
    Dec 31, 2017$0.15$0.22N/A-31.82%Miss-37.5%N/AN/AFeb 13, 2018$29.90M
    Sep 30, 2017$0.16$0.21N/A-23.81%Miss-15.8%N/AN/ANov 7, 2017$28.95M
    Jun 30, 2017$0.23$0.20N/A+15.00%Beat+109.1%N/AN/AAug 1, 2017$28.43M
    Mar 31, 2017$0.26$0.24N/A+8.33%Beat+116.7%N/AN/AMay 2, 2017$30.28M
    Dec 31, 2016$0.24$0.22N/A+9.09%Beat0.0%N/AN/AFeb 21, 2017$28.37M
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was $0.50, down 51.6% from the year before. It was $0.66 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025$0.50-51.6%
    Dec 31, 2024$1.04-16.5%
    Dec 31, 2023$1.25N/A
    Dec 31, 2022$1.27-13.6%
    Dec 31, 2021$1.47N/A
    Dec 31, 2020$1.45+15.1%
    Dec 31, 2019$1.26+10.5%
    Dec 31, 2018$1.14+42.5%
    Dec 31, 2017$0.80+21.2%
    Dec 31, 2016$0.66N/A

    Earnings Calls

    The 2 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 5,700 words across 8 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20265,6918
    2025Q4Dec 31, 20252,4134

    2026Q3 Earnings Call

    Opening remarks

    Jordan N. Freeman Chief Accounting Officer Thank you, operator. Welcome to NRC Health's earnings conference call for the second quarter ended June 30, 2026. I wanted to first let you know that we posted our earnings press release to the Investor Relations section on our website. On this call today, we have NRC Health's CEO, Trent Green, and CFO, Shane R. Harrison. Today's call will include statements related to the expected future results of our company, which are therefore forward-looking statements. Actual results may differ materially from these expectations due to a number of risks and uncertainties, including those described in our earnings release and other SEC filings. We will also reference non-GAAP financial measures. Definitions and reconciliations to the most comparable GAAP measures are provided in our earnings press release, which is available on our Investor Relations website. A replay of this call will also be posted to the same website. With that, let me turn our call over to our CEO, Trent Green.

    Trent Green CEO Thank you, Jordan. Good afternoon, everyone. Thank you for joining us for NRC Health's second quarter 2026 earnings call. Today, I will begin with an overview of our second quarter performance, discuss the momentum we are seeing across the business, and highlight how we continue to advance the next chapter of the NRC Health story with innovation across our product portfolio. We delivered another strong quarter of execution in the second quarter, reflected in our year-over-year total recurring contract value, or TRCV, and revenue growth. During the quarter, TRCV increased 11% year over year, with diversified growth across the business. Experience TRCV grew in the mid-teens compared to the prior year, driven by strong bookings activity during the first half of this year. Also notable in the quarter was the Governance Institute, which achieved its strongest bookings performance in seven years and grew its TRCV by nearly 10% year over year. This performance reinforces our conviction that healthcare leaders increasingly value trusted strategic guidance alongside technology-enabled solutions. Our TRCV growth reflects more than market demand. It demonstrates the effectiveness of our strategy. The sales organization we redesigned around buyers continues to perform well, enabling deeper engagement across experience, market insights, and the Governance Institute. By aligning with how health systems make decisions, we are creating larger, more strategic relationships and expanding our opportunity to deliver value across the enterprise. We are also seeing encouraging returns from our continued product investments, particularly those that connect experience measurement with experience improvement. Those capabilities were a key differentiator in the Landmark multisolution agreement we discussed last quarter and continue to resonate with healthcare organizations looking for partners who can move beyond insight to measurable action.

    Frequently Asked Questions About NRC

    When is NRC Health's next earnings date?

    NRC Health's next earnings report is expected for Feb 1, 2027.

    Did NRC beat earnings estimates last quarter?

    NRC Health reported EPS of $0.21 for the quarter ended Sep 30, 2026, in line with the $0.21 estimate.

    What EPS do analysts expect from NRC next quarter?

    The consensus EPS estimate for NRC Health for the quarter ending Mar 31, 2027 is $0.23 from 1 analyst, with estimates from $0.23 to $0.23.

    How often does NRC beat earnings estimates?

    NRC Health beat the EPS estimate in 4 of the 8 most recent quarters that had an estimate, with an average surprise of +19.15%.